Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Depixus

Depixus
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$2.4M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of a technology for extraction of genetic and epigenetic information from single molecules of DNA and RNA. The company's platform SIMDEQ (SIngle-molecule Magnetic DEtection and Quantification) allows for a full genome or genomic region to be analysed quickly and easily on a single integrated platform, with the investigator able to specify the level of sequence and epigenetic detail required, enabling its users with simple sample-preparation, sequential DNA fingerprinting, full-sequencing and epityping, together with a fast time-to-result and low operating costs.

Website
Formerly Known As
PicoSeq
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Primary Office
  • 3-5 Impasse Reille
  • 75014 Paris
  • France

+33 09 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Depixus’s full profile, request a free trial.

Depixus Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 15-Jun-2018 $2.4M 00.000 Completed Startup
3. Early Stage VC 29-Mar-2018 00.000 00.000 00.000 Completed Startup
2. Early Stage VC 04-Sep-2017 $2.33M $2.33M 00.000 Completed Product Development
1. Accelerator/Incubator 26-Nov-2013 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Depixus Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Depixus Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ontera Bio Venture Capital-Backed Santa Cruz, CA 000 0000 000000 00
000000 Formerly VC-backed Providence, RI 00 000.00 0000
0000000000 Venture Capital-Backed Menlo Park, CA 00 0000 00000000000 0000
0000000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
000 00000000 Venture Capital-Backed Pleasanton, CA 000 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Depixus Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Horizon 2020 Government 000 0000 000000 0
Arix Bioscience Venture Capital Minority 000 0000 000000 0
Agoranov Accelerator/Incubator 000 0000 000000 0

Depixus Executive Team (4)

Name Title Board
Seat
Contact
Info
Gordon Hamilton Co-Founder & Chief Executive Officer
Chas André Co-Founder & Chief Technology Officer
David Bensimon Co-Founder
Vincent Croquette Co-Founder

Depixus Board Members (4)

Name Representing Role Since Contact
Info
Edward Rayner Arix Bioscience Board Member 000 0000
John Berriman Self Chairman 000 0000
Ronald Lindsay Ph.D Self Board Member 000 0000

1 Former Board Member

You’re viewing 3 of 4 board members. Get the full list »